Novel Bristol Therapeutic to Target Atheroschlerosis
June 25, 2024
June 25, 2024
BRISTOL, England, June 25 (TNSres) -- The University of Bristol issued the following news release:
Scientists at the University of Bristol have uncovered a new disease driving mechanism which they are aiming to target to help treat the development of atherosclerotic plaques.
The project to develop the new therapeutic, known as IMSET, is being led by Jason Johnson, Professor of Cardiovascular Pathology within the Bristol Medical School: Translational Health Sciences (THS . . .
Scientists at the University of Bristol have uncovered a new disease driving mechanism which they are aiming to target to help treat the development of atherosclerotic plaques.
The project to develop the new therapeutic, known as IMSET, is being led by Jason Johnson, Professor of Cardiovascular Pathology within the Bristol Medical School: Translational Health Sciences (THS . . .